NeuroMetrix, Inc. Warrants
NUROW
NUROW was delisted on the 26th of May, 2020.
2 hedge funds and large institutions have $0 invested in NeuroMetrix, Inc. Warrants in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less capital invested
Capital invested by funds: $16K → $0 (-$16K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$953 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4 |
NUROW Hedge Fund Activity: Q3 2017 in Review
2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Warrants (NUROW) for Q3 2017, worth a combined $0 — down 100% from $16K a quarter earlier.
Fund positioning in NUROW was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $953. The largest seller was Sabby Management, exiting entirely with an estimated $7K sold.
- 2 institutional investors held NeuroMetrix, Inc. Warrants (NUROW) as of Q3 2017, down from 3 in Q2 2017.
- Funds reported $0 of NeuroMetrix, Inc. Warrants stock for Q3 2017, down 100% quarter-over-quarter.
- 1 fund opened new NeuroMetrix, Inc. Warrants positions in Q3 2017 and 1 closed out, a net change of 0 holders.
- The largest NeuroMetrix, Inc. Warrants buyer in Q3 2017 was Susquehanna International Group, an estimated $953 added.
- The largest NeuroMetrix, Inc. Warrants seller in Q3 2017 was Sabby Management, an estimated $7K sold.
Based on aggregated 13F filings for Q3 2017.